Maxion Therapeutics Ltd, a developer of antibody-based therapeutics for ion channel and GPCR-driven diseases, has appointed Santiago Arroyo as a non-executive director. Dr Arroyo, brings extensive medical and clinical development experience, most recently as chief development officer at Bicycle Therapeutics. He was senior neurologist at the Hospital Clinic of Barcelona, Spain and associate professor of neurology at the Medical College of Wisconsin, US. Dr Arroyo is currently a board member and chair of Lundbeck’s science committee and is a non-executive director at GlycoEra, a Swiss biotech company.
Copyright 2025 Evernow Publishing